Detalhe da pesquisa
1.
Effect of HLA Genotype on Anti-PD-1 Antibody Treatment for Advanced Renal Cell Carcinoma in the SNiP-RCC Study.
J Immunol;
2024 May 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38758119
2.
PTEN Regulates PI(3,4)P2 Signaling Downstream of Class I PI3K.
Mol Cell;
68(3): 566-580.e10, 2017 Nov 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29056325
3.
Different risk genes contribute to clear cell and non-clear cell renal cell carcinoma in 1532 Japanese patients and 5996 controls.
Hum Mol Genet;
31(12): 1962-1969, 2022 06 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35764097
4.
The lymphocyte-to-monocyte ratio as a significant inflammatory marker associated with survival of patients with metastatic renal cell carcinoma treated using nivolumab plus ipilimumab therapy.
Int J Clin Oncol;
2024 May 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38797782
5.
Comparison of perioperative outcomes and complications between intracorporeal, extracorporeal, and hybrid ileal conduit urinary diversion during robot-assisted radical cystectomy: a comparative propensity score-matched analysis from nationwide multi-institutional study in Japan.
Int J Clin Oncol;
29(1): 64-71, 2024 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37864612
6.
Genetic variations predicting progression with docetaxel and novel androgen-receptor pathway inhibitors.
Cancer Sci;
114(4): 1625-1634, 2023 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36602227
7.
Docetaxel versus abiraterone for metastatic hormone-sensitive prostate cancer with focus on efficacy of sequential therapy.
Prostate;
83(6): 563-571, 2023 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36661102
8.
Comparison of efficacy and medical costs between upfront docetaxel and abiraterone treatments of metastatic hormone-sensitive prostate cancer patients in real-world practice: a multicenter retrospective study.
World J Urol;
41(1): 67-75, 2023 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36520204
9.
Combination of docetaxel versus nonsteroidal antiandrogen with androgen deprivation therapy for high-volume metastatic hormone-sensitive prostate cancer: a propensity score-matched analysis.
World J Urol;
41(8): 2051-2062, 2023 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35596809
10.
Impact of trough abiraterone level on adverse events in patients with prostate cancer treated with abiraterone acetate.
Eur J Clin Pharmacol;
79(1): 89-98, 2023 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36378297
11.
Immunological risk and complement genetic evaluations in early onset de novo thrombotic microangiopathy after living donor kidney transplantation: A Japanese multicenter registry.
Clin Exp Nephrol;
27(12): 1010-1020, 2023 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37634218
12.
Preoperative prognostic model for localized and locally advanced renal cell carcinoma: Michinoku Japan Urological Cancer Study Group.
Int J Clin Oncol;
28(11): 1538-1544, 2023 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37740070
13.
Real clinical outcomes of nivolumab plus ipilimumab for renal cell carcinoma in patients over 75 years old.
Int J Clin Oncol;
28(11): 1530-1537, 2023 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37552353
14.
Advanced Tertiary Lymphoid Tissues in Protocol Biopsies are Associated with Progressive Graft Dysfunction in Kidney Transplant Recipients.
J Am Soc Nephrol;
33(1): 186-200, 2022 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34725107
15.
Trends in the use of local intervention for metastatic hormone-naïve prostate cancer: A multicenter retrospective study.
Int J Urol;
30(11): 969-976, 2023 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37403901
16.
Impact of germline HLA genotypes on clinical outcomes in patients with urothelial cancer treated with pembrolizumab.
Cancer Sci;
113(12): 4059-4069, 2022 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35848083
17.
Machine learning diagnosis by immunoglobulin N-glycan signatures for precision diagnosis of urological diseases.
Cancer Sci;
113(7): 2434-2445, 2022 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35524940
18.
Effect of upfront intensive therapy on oncological outcomes in older patients with high tumor burden metastatic castration-sensitive prostate cancer: A multicenter retrospective study.
Prostate;
82(13): 1304-1312, 2022 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35747992
19.
Does castration status affect docetaxel-related adverse events? :Identification of risk factors for docetaxel-related adverse events in metastatic prostate cancer.
Prostate;
82(14): 1322-1330, 2022 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35767376
20.
Prognostic significance of pathogenic variants in BRCA1, BRCA2, ATM and PALB2 genes in men undergoing hormonal therapy for advanced prostate cancer.
Br J Cancer;
127(9): 1680-1690, 2022 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35986085